# MIRA Pharmaceuticals, Inc. (MIRA) · Edgar & Edgarette company card

> Figures from the company's own SEC filings.

SEC CIK 1904286 · fiscal year ended — · 0 audited years read · [page](https://www.pops4.com/boards/company/MIRA) · [JSON](https://www.pops4.com/boards/company/MIRA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | — |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | — |
| Operating cash flow | — |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | — |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures


## Edgarette's reading

The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-07-31 ([filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226035665/0001493152-26-035665-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-06-08 ([filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226027751/0001493152-26-027751-index.htm))

## Recent filings

- 8-K · filed 2026-10-28 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226048978/0001493152-26-048978-index.htm)
- 8-K · filed 2026-10-22 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226048022/0001493152-26-048022-index.htm)
- 8-K · filed 2026-09-17 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226043051/0001493152-26-043051-index.htm)
- 8-K · filed 2026-09-16 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226042927/0001493152-26-042927-index.htm)
- 8-K · filed 2026-09-01 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226040930/0001493152-26-040930-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/1904286/000149315226037366/0001493152-26-037366-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001904286.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1904286

## Cite

POPS4, Edgar & Edgarette: MIRA Pharmaceuticals, Inc. (MIRA) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/MIRA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.